Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
GHII just released good news:
http://finance.yahoo.com/news/Gold-Horse-International-Inc-prnews-2552889852.html?x=0&.v=74
I am hoping for over 4
Sounds interesting what's the target??nk:)
news: China Sun Group High-Tech Co. Signs LOI to Jointly Produce Finished Li-Ion Batteries for Electric Vehicle
LIAONING PROVINCE, China, Oct. 27 /PRNewswire-FirstCall/ -- China Sun Group High-Tech Co. (OTC Bulletin Board: CSGH), which through its wholly-owned subsidiary Dalian Xinyang High-Tech Development Co. Ltd. ("DLX") has the second largest cobalt series production capacity in the People's Republic of China ("PRC"), announced today that on September 27, 2009, DLX signed a Letter of Intent (LOI) with Beijing Zhongxinlian Shuangsheng Sci-Tech Co., Ltd. to jointly produce finished lithium ion (li-ion) batteries under the registered brand name "ShenKun." The 100An serial power ShenKun batteries are made with DLX's lithium iron phosphate product, an alternative, environmentally-friendly energy component.
Since DLX began production of its new li-ion product in May 2009, two of China's leading battery producers, Shandong Shengong KP-Power Co., Ltd. and Beijing Zhongxinlian Shuangsheng Sci-Tech Co., Ltd., have successfully completed testing of li-ion batteries using DLX components. The companies are now demonstrating a prototype battery to electric vehicle manufacturers to facilitate sales of finished li-ion products. In addition, China Sun Group has 21 customers undergoing technical testing of its new li-ion product.
Bin Wang, CEO of China Sun Group, said, "The goal of our strategic agreement with Beijing Zhongxinlian is to accelerate the commercialization of our green, li-ion battery product to the global electric vehicle manufacturing market. With the production of finished li-ion batteries, China Sun Group looks forward to expanding its business worldwide as a complete, end-to-end battery product manufacturer."
DCRD....Looks like the MM's are walking it up nk:)
DCRD competition: Market Wire PAPER INDUYSTRY
AnalystChoice.com Brings You the Best Complimentary Research Report on TAP, PKG, TGT, RJF, TC and SII
Released : Tuesday, September 29, 2009 6:35 AM
NEW DELHI, INDIA -- (MARKET WIRE) -- 09/29/09 --
Analyst Choice has combined some of the
best financial and technical minds worldwide to bring you an array of free
quality equity research and reporting. Today we have begun in-depth
reporting on our website evaluating the current market condition of Molson
Coors Brewing Company (NYSE: TAP), Packaging Corp. of America (NYSE: PKG),
Target Corp. (NYSE: TGT), Raymond James Financial Inc. (NYSE: RJF),
Thompson Creek Metals Company Inc. (NYSE: TC) and Smith International Inc.
(NYSE: SII).
You can now access these reports with many others by signing up for free at
http://www.analystchoice.com/
While the world economy undergoes enormous pressure and unprecedented
actions are been taken to avoid the worst and boost the shrinking global
economic growth, our analysts brings you a bird's eye view of how the big
players in the different key sectors and industries of the NASDAQ and NYSE,
are coping. Sign up now by visiting the following link and receive free
access to the CFA reports listed in this release.
http://www.analystchoice.com/
Our research and reporting style takes you closer to the basics and allows
you to understand the company's lifecycle on a peer-to-peer and company-to-
industry level.
By opting to register for our free membership on
http://www.analystchoice.com/, you will have access to these reports &
opinions. You can expect to have a brief analysis on the different key
aspects of these companies, that is:
OK, I'm convinced. Lol
Seriously China is definitely buying....
Check this out nk:)
http://www.bloomberg.com/apps/news?pid=20601087&sid=aKvtw723S1c0
...DCRD competition - Int'l Paper is ticker IP
International Paper (NYSE:IP) is a global paper and packaging company with manufacturing operations in North America, Europe, Latin America, Russia, Asia and North Africa. Its businesses include uncoated papers and industrial and consumer packaging, complemented by xpedx, the company's North American distribution company. Headquartered in Memphis, Tenn., the company employs more than 61,500 people in more than 20 countries and serves customers worldwide. 2008 net sales were approximately $25 billion.
Check out DCRD today!
The Seven Reasons Why You Should be
Bullish on China...
1 of every 5 people in the world live there
100 cities with over 1 million people (only 9 in the U.S.)
300 million people under age 14 representing future consumers who want a standard of living similar to that of Western societies
#1 market for mobile phones with 461 million users (larger than the entire U.S. population)
#2 market for Internet users at 137 million, and growing despite pervasive censorship
GDP growth average 9.37% per year for the last 25 years running
A central government committed to lifting the masses to a consumption driven middle and upper class status in one generation
Ty I'll buy on the dips then....nk:)
yes, it will be volatile this coming week or two, with volume starting to pick up slowly....price may even dip for a short time but, from an invesment standpoint, the realistic goal is much higher than at these levels. So, a patient investor will WIN big on DCRD by Q4, 2009.
I would like to see some more volume though.
good one.....now is the time to accumulate...I think over the next few weeks is the best opportunity....once it gets in the teens, the chances for ten-bagger decrease.
DCRD...nibbled at it a little. Glty nk:)
DCRD - watch this one! In 1997, China had a 3.2% market share in the global decor paper market; by 2010, it is expected that China will have a 25% market share. With a current capacity of 96 million meters of decor paper capacity, DCRD i.e. Dongguan Chditn Paper is one of the largest high-class decor paper manufacturers in China with an estimated 7% market share.
expect some trading to come in soon! up in PPS
It is trading but with low volume.....about 1-3 weeks away from institutional support and professional IR campaign coming into it!
DCRD...
Sounds good. Is it trading yet??
new...DCRD: $6.8 million net income (after taxes) 12-31-08 audited
no worries here GLTY nk:)
CSGH::: Net income for the three months ended November 30, 2008 was $1,809,975, an increase of $1,071,493 or 145% as compared to $738,482
China Shoe Holdings Holds Successful Media Event in Shanghai, China
Wednesday June 4, 9:14 am ET
SHANGHAI, China, June 4 /Xinhua-PRNewswire-FirstCall/ -- On May 28, 2008, China Shoe Holdings (OTC Bulletin Board: CHSH - News) held a media event to promote its own brands, Kanggies and CCR, to the public in Shanghai. More than twenty reporters from various TV stations, newspapers and trade publications, as well as representatives from dozens of department stores and shopping malls attended the event.
Kanggies brand positions in the medium to high-priced market segment with white-collar working women being the main target consumers. CCR brand's focus is on economically-priced shoes targeting the mass public, especially consumers residing in city suburbs or less developed counties. China Shoe will promote both brands through its self-owned retail stores as well as other franchised outlets. Two Kanggies stores have already been opened and ten more are expected to commence by July of 2008. A plan to open up 30 CCR stores is under consideration and it will move forward in mid June.
Mr. Gu Xianzhong, President and CEO of China Shoe Holdings, indicated that this media event demonstrates how the company is rapidly executing its retail strategy. Having conducting vigorous research during the past six months, the management is optimistic about the PRC's footwear retail market and the company's ability to become a major player in it.
About China Shoe Holdings, Inc.
Based in Shanghai, China, China Shoe Holdings manufactures, designs and sells private label and its own branded footwear throughout China and in overseas markets, principally Japan. China Shoe Holdings has its own manufacturing facilities located in China. China Shoe Holdings has built a diversified customer base throughout China and overseas.
CHSH.OB board:
http://investorshub.advfn.com/boards/board.aspx?board_id=9995
Lotus Actively Increasing Its Share of China’s Pharma Market
http://seekingalpha.com:80/article/73229-lotus-actively-increasing-its-share-of-chinas-pharma-market?source=d_email
Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results
http://biz.yahoo.com/prnews/080417/cnth025.html?.v=16
Beijing Logistic, Inc BJGL.....
Here is a find for those looking for "China Plays" with huge potential
http://biz.yahoo.com/bw/080416/20080416006075.html?.v=1
Beijing Logistic, Inc. Announces Strong Year-End 2007 Financial Results
Wednesday April 16, 4:30 pm ET
-- 2007 Revenues Increased 51.8% to $85.9 million
-- 2007 Net Income Increased 41.7% to $13.5 million
-- 2007 EPS reached $0.14 per diluted share
NEW YORK & BEIJING--(BUSINESS WIRE)--Beijing Logistic, Inc. (the "Company") (OTC Bulletin Board: BJGL - News), one of China’s largest third-party logistics providers, specializing in books & magazines, agricultural products and Chinese traditional medicine storage and shipping, today announced operating results for year-end 2007.
ADVERTISEMENT
2007 Full Year Highlights
Net revenues for the full year 2007 increased 51.8% to $85.9 million compared to $56.6 million for the full year 2006:
The major contribution of this growth was the expansion of our books logistics business. In 2007, revenues from books and magazines logistics management increased 66.8% from 2006, to approximately $51.9 million USD.
Ms. Zhang, Chief Executive Officer of Beijing Logistic, explained, “The growth was due to our continued focus on expanding warehouse service offerings as a third party logistics trustee company to the publishing Industry. We built new distribution centers in large cities to organize and manage inventory for many publishers, and as a result, we earned profit not just from book and magazine shipping, but also from the management service in the warehouse. We diversified services, and improved efficiency in order to satisfy the requirement of different clients, and the client base in the publishing business segment has increased.”
In addition, the revenues from the agricultural products and traditional medicine business segments also increased 34.4% and 38.5%, reaching $19.6 million USD and $13.9 million USD, respectively from 2006 to 2007.
Gross profit for 2007 was $20.16 million USD, or 23.47% of net sales, as compared $14.15 million USD, or 25% of net sales in 2006:
Gross Profit increased approximately $6.01 million USD due to higher revenues, however, gross margin decreased 1.53% due to the following: relatively higher increase of our cost of revenues: $64,186,115 USD in fiscal 2007 (or 74.7% of net revenues), an increase of $22,917,948 USD (or approximately 55.5%) over the cost of revenues in fiscal 2006; higher salaries and benefits; higher fuel costs, and professional fees related to going public in the United States.
Full year 2007 net income was $13.5 million USD, an increase of approximately $3.9 million USD, or 41.7%, from the full year 2006.
Working capital was $11,552,857 USD as of December 31, 2007.
Cash and cash equivalents were $13,755,350 USD as of December 31, 2007, and current assets totaled $15,027,321 USD as of December 31, 2007. Total current liabilities were $3,474,464 USD as of December 31, 2007. During 2007, the Company generated $15.6 million USD in cash from operations, an increase of approximately $4.8 million USD over the 2006 level, which reflected the increase in revenue in 2007.
Ms. Zhang Yu, Chief Executive Officer of Beijing Logistic summarized, "2007 was a notable year for Beijing Logistic, we were striving to become the largest book logistics company in China, the highest ranked third-party logistics company, and the most renowned logistics company.”
“About the future”, she continued, “for 2008, our economic activity is expected to continue to expand with a moderate pace. As a result, we expect our revenue trends to moderate in 2008, with growth driven by books and magazine logistics management. In order to support long-term volume growth, we expect to open additional distribution centers in China, launch new warehouses, and improve our warehouse storage volume and operational functionality to plan, receive, process, and invoice activities.”
About Beijing Logistic, Inc
Beijing Logistic, Inc. conducts business in China through its operational subsidiary-Beijing Baolong Logistics, Co. Ltd. It is one of China’s largest third-party logistics providers, specializing in Books & Magazines, agricultural products and Chinese traditional medicine storage and shipping. It provides full-service, client-specific solutions to clients in the industry above, combining the flows of goods, information, and funds. For more company information, please visit its website: www.beijinglogisticinc.com.
Lotus Pharma (LTUS) Income up 153%
They just filed 10k after bell, and cleared .27/share in 2007. Stock closed at just .71/share today. Should move big rest of week. I think most were expecting .17-.19 for the year....not .27/share.
http://biz.yahoo.com/e/080414/ltus.ob10-k.html
CDS nice news -
China Direct Creates New Foreign Invested Entity to Expand Magnesium Production Base to Inner Mongolia
Wednesday February 27, 8:00 am ET
New Entity to Add a Total of 20,000 Metric Tons of Annual Production Capacity
DEERFIELD BEACH, Fla., Feb. 27 /PRNewswire-FirstCall/ -- China Direct, Inc. (Amex: CDS - News), a U.S. company that owns controlling stakes in a diversified portfolio of Chinese entities and assists Chinese businesses in accessing the U.S. capital markets, has created a new foreign invested entity in China related to its previously announced letter of intent on December 19, 2007. The new entity named Baotou Changxin Magnesium Co., Ltd. ("Xin Magnesium") based in Baotou, Inner Mongolia, China, will commence operations in the second quarter of 2008.
China Direct will contribute approximately $7.1 million to obtain a 51% interest in Xin Magnesium. Xin Magnesium will construct a magnesium refinery with an annual production capacity of 20,000 metric tons. China Direct forecasts the first stage of construction, adding 12,000 metric tons of annual capacity will be completed in the second quarter of 2008; the second stage of construction, adding an additional 8,000 metric tons of annual capacity should be completed by June 2009.
Management further estimates this venture, assuming an average price of $3,000 per metric ton, should contribute approximately $21 million in revenue to China Direct in 2008. At full capacity the facilities should be capable of producing 20,000 metric tons of magnesium or $60 million in revenue annually under the current plan.
Dr. James Wang, Chairman and CEO of China Direct, stated, "We are excited to have closed on this new operation as we continue to see magnesium industry trends remaining favorable for the foreseeable future. This facility will implement high temperature air combustion technology, also known as flameless combustion to reduce production costs as we seek to maximize gross margins at these state of the art new facilities. We look forward to continued opportunistic expansion of our magnesium segment in the coming years."
Dr. Wang concluded, "This investment demonstrates management's commitment to our magnesium division and will increase China Direct's overall magnesium production capacity to approximately 50,000 metric tons annually by the end of the second quarter of 2008. With this additional capacity, we now anticipate that our magnesium division, through both manufacturing and wholesale distribution, will sell approximately 80,000 metric tons in 2008, solidifying our position as a global leader in this industry."
About China Direct, Inc.
China Direct, Inc. (Amex: CDS - News) is a diversified management and advisory services organization headquartered in the U.S. Our management services division acquires a controlling interest in entities operating in China. Our ownership control enables China Direct to provide management advice, as well as financing to Chinese entities. This infrastructure creates a platform to expand business opportunities globally while effectively and efficiently accessing the U.S. capital markets. Our advisory services division provides comprehensive advisory and consulting services critical to the success of Chinese entities seeking to access the U.S. capital markets. As a direct link to China, China Direct serves as a vehicle allowing investors to directly participate in the rapid growth of the Chinese economy in a diversified and balanced manner. For more information about China Direct, please visit http://www.chinadirectinc.com.
Yes, LTUS restated income higher by a penny last week.
Previous repoft for first 3 quarters had LTUS making .14/share, and now it's .15/share.
They also (in their private placement news just out today) have a make good of $13.8M in net income for 2008.
LTUS (Lotus Pharma) going to Nasdaq
Private placement deal (at prices above yesterday's close) includes Nasdaq listing in $5M deal.
Based on 2008 projections, LTUS has a PE under 5 here.
http://biz.yahoo.com/prnews/080226/cntu016.html?.v=44
Morning all. An interesting one here:
CPHI.ob (2.79). China Pharma Holdings, Inc. Receives $5.6 Million in Purchase Orders for Pusen OK (Generic Aleve-D(TM) Product)
The Company Announces Unaudited Preliminary 2007 Revenue of Approximately $33 Million, Representing an Over 50% Increase From 2006
NEW YORK and HAIKOU, China, Feb 25, 2008 /Xinhua-PRNewswire-FirstCall via COMTEX/ -- China Pharma Holdings, Inc. ("China Pharma") which develops, manufactures, and markets generic and branded bio-pharmaceutical products in China, today announced it received new purchase orders from one of its main distributors for its Pusen OK, a generic version of Aleve-D(TM). The orders total approximately $5.6 million, are expected to be recognized during 2008 and carry associated gross margins higher than 55 percent, which is approximately 10 percent higher than the Company's average gross margins during the past year.
Separately, the Company announced preliminary revenues for 2007 of at least $33 million, representing an over 50 percent growth compared to 2006. Pusen OK contributed approximately $4.1 million in revenues during 2007.
Since mid January, several of the worst snowstorms in decades struck most of central and southern China. As a result of this and other factors related to the colder weather and lower temperatures in China, the incidence of flu and cardiovascular diseases surged dramatically, and has increased the demand for China Pharma's cold medicine Pusen OK, the only generic version of Aleve-D(TM) brand with an antihistamine in China. Compared to other cold medicines in China's market, Pusen OK is among the most effective with 12-hour relief and does not cause sleepiness as a side effect.
Ms. Zhilin Li, president and CEO of China Pharma said: "I am very pleased to announce this new order for our Pusen OK product as our focused sales and marketing efforts have successfully created awareness among many of our major pharmaceutical distributors. The Company recently initiated production to fulfill these orders and anticipate initial contributions during the first quarter. Further, we expect Pusen OK will be a significant contributor to our growth during 2008, and will be supported by increased sales from our existing product portfolio in addition to the launch of two new products during the first half of 2008."
About China Pharma Holdings, Inc.
China Pharma Holdings, Inc. develops, manufactures, and markets generic and brand bio-pharmaceutical products in China that treat a wide range of conditions, including infections, hepatitis, cardiovascular and CNS diseases, and other prevailing diseases. Helpson Bio-pharmaceutical Co., Ltd (Helpson), a specialty pharmaceutical company headquartered in Haikou City, Hainan province in China, is a wholly owned subsidiary of China Pharma Holdings. For more information about China Pharma Holdings, Inc., please visit http://www.chinapharmaholdings.com .
1.00++ is definitely alright by me, lol. Looking for bid to UT soon enough. GL Eagle.
I don't have any kind of target price in mind...haven't even purchased any of the stock as yet Jong...sorry! tuna
Hi temco, watcha into?
You still in that one?
Ver interesting ONMC play, target?
I like the story. Needs time and we will see 1.00 +++
Just saw that as well. Be watching this one like a hawk today. Thanks Eagle and GLTY.
HAVA float 10mil.
its has business with Indonesia.
THe PR today shows that SMGH is on the right track.
Thats definitely what caught my eye, the 20 million retired! GL Chef.
Excellent. Thanks for the info Eagle. Kepping this one on the books. GLTY.
is any of you in APWR?
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |